(Q44017833)

29 November 2017

Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma (English)

1 reference

29 November 2017

Shoji Yamazaki

1

1 reference

29 November 2017

Tatuo Morita

2

1 reference

29 November 2017

Hitoshi Endo

3

1 reference

29 November 2017

Toshiro Hamamoto

4

1 reference

29 November 2017

Masaki Baba

5

1 reference

29 November 2017

Yoshiko Joichi

6

1 reference

29 November 2017

Sanae Kaneko

7

1 reference

29 November 2017

Yoshihito Okada

8

1 reference

29 November 2017

Toru Okuyama

9

1 reference

29 November 2017

Hoyoku Nishino

10

1 reference

29 November 2017

Akihiko Tokue

11

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

29 November 2017

1 reference

29 November 2017

183

1 reference

29 November 2017

1

1 reference

29 November 2017

23-30

1 reference

Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Saponins isolated from Allium chinense G. Don and antitumor-promoting activities of isoliquiritigenin and laxogenin from the same drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

The potent anti-tumor-promoting agent isoliquiritigenin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

A murine renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Accurate identification of experimental pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Roles of nitric oxide in tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Inhibition of Adenosine 3', 5'-Cyclic Monophosphate Phosphodiesterase by Flavonoids from Licorice Roots and 4-Arylcoumarins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900113-1

7 January 2021

10.1016/S0304-3835(02)00113-1

Identifiers

DOI

1 reference

29 November 2017

1 reference